Showing results (1211-1220 of 1,722) with videos related to

Sort By:
Pageof 173
Leukemia & Lymphoma|June 25, 2011
Methotrexate area under the curve as a prognostic factor in primary central nervous system lymphoma treated with immunochemoradiotherapyPatrick G Morris, Lauren E Abrey, Anne S Reiner, et al.
Journal of Neuro-Oncology|December 29, 2011
Bevacizumab for glioblastoma refractory to vascular endothelial growth factor receptor inhibitorsSamuel A Goldlust, Robert Cavaliere, Herbert B Newton, et al.
Pediatric Nephrology (Berlin, Germany)|January 1, 1990
Intravenous immunoglobulin in minimal change nephrotic syndrome: a crossover trialP C Rowe, R H McLean, E J Ruley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2009
The regulation of liver cell survival by complementMaciej M Markiewski, Robert A DeAngelis, Christoph W Strey, et al.
The ISME Journal|January 15, 2026
Warming mitigates root exudate-induced priming effects via changes to microbial biomass, community structure, and gene abundanceNikhil R Chari, Kristen M DeAngelis, Arturo A Aguilar, et al.
Glycobiology|October 23, 2012
Hyaluronan in cytosol--microinjection-based probing of its existence and suggested functionsHanna Siiskonen, Kirsi Rilla, Riikka Kärnä, et al.
Archives of Physical Medicine and Rehabilitation|June 2, 2019
The Rehabilitation Enhancing Aging Through Connected Health Prehabilitation TrialJonathan F Bean, Lorna Brown, Tamara R DeAngelis, et al.
The Canadian Journal of Cardiology|May 22, 1998
Lipid altering or antioxidant vitamins for patients with coronary disease and very low HDL cholesterol? The HDL-Atherosclerosis Treatment Study DesignB G Brown, X Q Zhao, A Chait, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2004
C3a and C3b activation products of the third component of complement (C3) are critical for normal liver recovery after toxic injuryMaciej M Markiewski, Dimitrios Mastellos, Ruxandra Tudoran, et al.
The American Journal of Cardiology|February 5, 2004
Safety and tolerability of simvastatin plus niacin in patients with coronary artery disease and low high-density lipoprotein cholesterol (The HDL Atherosclerosis Treatment Study)Xue-Qiao Zhao, Josh S Morse, Alice A Dowdy, et al.
Pageof 173